Company intelligence / Profile preview

BioART

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

BioArt Co., Ltd. is a South Korean biotechnology company specializing in the production and distribution of high-quality research reagents for the life sciences industry. The company's core product portfolio includes a wide range of recombinant proteins, monoclonal and polyclonal antibodies, and ELISA kits used in academic and industrial research. BioArt focuses on providing essential tools for proteomics and cell biology studies, supporting drug discovery and diagnostic development. In addition to its own manufactured products, the company often acts as a distributor for international biotech brands within the Korean market.

Modalities: Recombinant proteinAntibodyBiologic
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on BioART.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioART.

Explore the full profile